Artelo Biosciences Inc. Warrant (ARTLW) Financials

$0.01

$0.00 (9.80%)

As on 17-Jun-2024 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	--	9.93	10.29	10.29	10.29	7.44
Operating Profit (EBIT)	--	-9.93	-10.29	-10.29	-10.29	-7.44
Other Income	--	--	--	--	--	--
Profit before Tax	--	-9.29	-10.08	-10.08	-10.08	-7.44
Provision for Tax	--	--	-0.21	-0.21	--	0.00
Profit after Tax (Net Income)	--	-9.29	-9.87	-9.87	-10.08	-7.44
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Shareholder's Funds	9.54	11.75	19.40	19.40	19.40	12.04
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.10	--	0.02	0.02	0.02	0.07
Current Liabilities	0.72	1.29	1.00	1.00	1.00	0.53
Total Liabilities	0.72	13.04	20.42	20.42	20.42	12.64

Assets ($ Mln)	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Non-Current Assets	2.17	2.06	2.10	2.10	2.10	2.32
Current Assets	8.19	10.98	18.32	18.32	18.32	10.32
Total Assets	11.08	--	20.42	20.42	--	12.64
Total Debt*	--	--	0.06	0.06	--	0.10
Net Current Assets	7.47	9.69	9.69	17.32	17.32	9.79

Cashflow ($ Mln)	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Cash From Operating Activities	--	-8.21	-8.01	-8.01	-8.01	-6.14
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	0.57	-0.04	--	--	14.11
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
ROCE (%)	--	-59.51	-50.72	-50.81	-63.94	-61.28
ROE (%)	--	-59.63	-50.89	-50.89	-64.13	-61.76
ROA (%)	--	-55.51	-48.35	-48.35	-61.00	-58.86
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	--	-38.25	--	-57.81
Net Profit Growth (%)	--	5.92	2.07	-32.77	-35.58	-59.77
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	1.70	1.70	1.74	1.34
Close Price ($)	0.02	0.04	0.04	0.04	0.13	0.18
High Price ($)	0.21	0.21	0.21	0.42	0.50	0.92
Low Price ($)	--	--	0.03	0.03	0.03	0.11
Market Cap ($ Cr)	0.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Debt to Equity	--	--	0.00	0.00	--	0.01
Short term debt to equity ratio	--	--	0.00	0.00	--	0.00
Current Ratio	11.36	8.51	18.36	18.36	18.36	19.61
Quick Ratio	11.36	--	--	--	--	--
Interest Coverage	--	--	-2,057.40	-2,057.40	--	--

Operating Efficiency Ratios	TTM	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.